Aminosalicylates and Other Anti-Inflammatory Compounds for Irritable Bowel Syndrome

Publisher： Karger

E-ISSN： 1421-9875|27|1|115-121

ISSN： 0257-2753

Source： Digestive Diseases, Vol.27, Iss.1, 2010-03, pp. : 115-121

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Overlap between Irritable Bowel Syndrome and Inflammatory Bowel Disease

By  

Digestive Diseases, Vol. 27, Iss. 1, 2010-03 ,pp. : 48-54

Karger

Access to resources Recommend Favorite

The Placebo Response Rate in Irritable Bowel Syndrome and Inflammatory Bowel Disease

By  

Digestive Diseases, Vol. 27, Iss. 1, 2010-03 ,pp. : 68-75

Karger

Access to resources Recommend Favorite

Pharmacological Treatment of the Irritable Bowel Syndrome and Other Functional Bowel Disorders

By  

Digestion, Vol. 73, Iss. 1, 2006-02 ,pp. : 28-37

Karger

Access to resources Recommend Favorite

Risks of Inflammatory Bowel Disease Treatment with Glucocorticosteroids and Aminosalicylates

By  

Digestive Diseases, Vol. 31, Iss. 3-4, 2013-11 ,pp. : 368-373

Karger

Access to resources Recommend Favorite

Relationship of Bloating to Other GI and Menstrual Symptoms in Women with Irritable Bowel Syndrome

By Heitkemper Margaret M.   Cain Kevin C.   Jarrett Monica E.   Burr Robert L.   Crowell Michael D.   Woods Nancy F.  

Digestive Diseases and Sciences, Vol. 49, Iss. 1, 2004-01 ,pp. : 88-95

Springer Publishing Company

Access to resources Recommend Favorite